Fundz

Johnson & Johnson makes a significant investment in Sail Biomedicines, committing $785 million up front, including a $465 million equity investment, to advance its lead CAR-T program.

PRIVATEJul 30, 2026

Amount Raised

$465 Million

Round Type

Venture

CambridgeBiotechnologyHealth CareArtificial Intelligence

Investors

Johnson & Johnson

Description

Johnson & Johnson announced a deal to work with biotechnology firm Sail Biomedicines, including an initial equity investment of $465 million. The funding aims to help advance Sail's CAR-T therapy program, which is still in preclinical testing. J&J has also secured an exclusive option to acquire Sail for $2.58 billion in the future. This represents a strategic move into in vivo cell therapy by one of the industry giants.

Quick answer

Sail Biomedicines raised $465 Million in a funding round, dated July 30, 2026. Investors: Johnson & Johnson. Sail Biomedicines is based in Cambridge, Massachusetts, United States.

How much did Sail Biomedicines raise?
Sail Biomedicines raised $465 Million in a funding round on July 30, 2026.
Who invested in Sail Biomedicines?
Johnson & Johnson is named as investors in this round.
What does Sail Biomedicines do?
Sail Biomedicines, a Flagship Pioneering company, is generating tomorrow’s medicines today through the language of life.
Where is Sail Biomedicines based and how big is it?
Sail Biomedicines is based in Cambridge, Massachusetts, United States. Fundz records about 130 employees.
Who are the decision-makers at Sail Biomedicines?
Fundz holds 1 contact at Sail Biomedicines, including the Director, Operations and Facilities. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Sail Biomedicines that raised within 45 days of this round, from Fundz verified event records.

  • Epsilon Health raised $28M on September 10, 2026.
  • Positron raised $875M (Series C) on September 10, 2026.
  • IMPLICITY raised $41M on September 9, 2026.
  • Ridge Biotechnologies raised $38M (Seed) on September 9, 2026.
  • Anemo Labs raised $950K (Pre-Seed) on September 9, 2026.
  • Hi Rasmus raised $50M on September 6, 2026.

Who to call at Sail Biomedicines, and when

A new round usually means Sail Biomedicines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sail Biomedicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sail Biomedicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sail Biomedicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sail Biomedicines

Location

140 First St

Cambridge, Massachusetts, United States

About

Sail Biomedicines, a Flagship Pioneering company, is generating tomorrow’s medicines today through the language of life. Sail’s platform combines first-in-category translatable circular RNA technology (Endless RNA™ or eRNA), and proprietary programmable nanoparticles, utilizing natural components, to comprehensively program medicines for the first time. By leveraging its rapid prototyping and testing bioplatform, Sail is building a wealth of data, enabling unparalleled use of state-of-the-art AI techniques for the integrative design of RNA medicines with unprecedented performance and broad applicability. For more, visit www.sail.bio and follow us on X (formerly Twitter) @SailBiomeds and on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sail Biomedicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsScott, Director, Operations and Facilities hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sail Biomedicines's next move

See what Strategic adds

Sail Biomedicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.